Meditolp (Tolperisone Hydrochloride)

Tolperisone Hydrochloride acts on the central nervous system to reduce skeletal muscle hypertonia, making it useful for several musculoskeletal conditions.

• Muscle spasm: helps relax involuntary muscle contractions and reduces associated pain.
• Spasticity: decreases muscle tone in conditions such as post‑stroke or multiple sclerosis‑related spasticity.
• Low back pain: alleviates pain by reducing muscle tension in the lumbar region.
• Cervical pain: eases neck muscle stiffness and discomfort.

• Tolperisone Hydrochloride is a centrally acting muscle relaxant that blocks voltage‑gated sodium channels in spinal cord neurons, diminishing the transmission of reflex arcs. This inhibition reduces spinal reflex activity and muscle hypertonia, leading to relaxation of skeletal muscles without significant direct peripheral muscle effects.

Tolperisone Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Dizziness: sensation of light‑headedness or unsteadiness.
• Nausea: mild to moderate feeling of stomach upset.
• Dry mouth: reduced salivation causing throat discomfort.
• Headache: mild to moderate cranial pain.
• Fatigue: general feeling of tiredness.
• Gastrointestinal upset: occasional abdominal discomfort or dyspepsia.

Serious or Rare Side Effects

• Hypotension: marked drop in blood pressure that may cause fainting.
• Allergic reactions: rash, itching, or swelling of the face and throat.
• Liver enzyme elevation: abnormal liver function test results.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Blood dyscrasias: rare cases of leukopenia or thrombocytopenia.
• Cardiac arrhythmia: irregular heart rhythm in susceptible individuals.

When prescribing Tolperisone Hydrochloride, clinicians should consider several safety measures.

• Assess renal and hepatic function: adjust use if impairment is present.
• Monitor blood pressure: watch for hypotensive episodes, especially in the elderly.
• Avoid use in known hypersensitivity: discontinue if allergic signs appear.
• Use caution in elderly patients: increased susceptibility to dizziness and falls.
• Do not discontinue abruptly: tapering may be advisable to avoid rebound spasm.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Tolperisone Hydrochloride can interact with other medications, requiring careful management.

Major Interactions (Avoid)

• Concomitant CNS depressants (e.g., benzodiazepines, opioids): may enhance sedation and respiratory depression.
• Antihypertensive agents: additive hypotensive effect.
• Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase Tolperisone plasma concentrations.

Moderate Interactions (Monitor Closely)

• Anticholinergic drugs: may exacerbate dry mouth.
• Diuretics: potential electrolyte disturbances.
• Anticoagulants: possible increase in bleeding tendency.